Genetic Discrimination Between LADA and Childhood-Onset Type 1 Diabetes Within the MHC. Academic Article uri icon

Overview

abstract

  • OBJECTIVE: The MHC region harbors the strongest loci for latent autoimmune diabetes in adults (LADA); however, the strength of association is likely attenuated compared with that for childhood-onset type 1 diabetes. In this study, we recapitulate independent effects in the MHC class I region in a population with type 1 diabetes and then determine whether such conditioning in LADA yields potential genetic discriminators between the two subtypes within this region. RESEARCH DESIGN AND METHODS: Chromosome 6 was imputed using SNP2HLA, with conditional analysis performed in type 1 diabetes case subjects (n = 1,985) and control subjects (n = 2,219). The same approach was applied to a LADA cohort (n = 1,428) using population-based control subjects (n = 2,850) and in a separate replication cohort (656 type 1 diabetes case, 823 LADA case, and 3,218 control subjects). RESULTS: The strongest associations in the MHC class II region (rs3957146, β [SE] = 1.44 [0.05]), as well as the independent effect of MHC class I genes, on type 1 diabetes risk, particularly HLA-B*39 (β [SE] = 1.36 [0.17]), were confirmed. The conditional analysis in LADA versus control subjects showed significant association in the MHC class II region (rs3957146, β [SE] = 1.14 [0.06]); however, we did not observe significant independent effects of MHC class I alleles in LADA. CONCLUSIONS: In LADA, the independent effects of MHC class I observed in type 1 diabetes were not observed after conditioning on the leading MHC class II associations, suggesting that the MHC class I association may be a genetic discriminator between LADA and childhood-onset type 1 diabetes.

authors

publication date

  • December 16, 2019

Research

keywords

  • Diabetes Mellitus, Type 1
  • Genes, MHC Class I
  • Genes, MHC Class II
  • Genetic Testing
  • Latent Autoimmune Diabetes in Adults

Identity

PubMed Central ID

  • PMC6971787

Scopus Document Identifier

  • 85078380035

Digital Object Identifier (DOI)

  • 10.2337/dc19-0986

PubMed ID

  • 31843946

Additional Document Info

volume

  • 43

issue

  • 2